Page last updated: 2024-08-23

taurolidine and Liver Dysfunction

taurolidine has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koivusalo, A; Merras-Salmio, L; Mutanen, A; Pakarinen, MP; Rintala, R; Ylinen, E	1
Bobrich, E; Braumann, C; Jacobi, CA; Menenakos, C; Rogalla, S; Stuhldreier, B	1

Other Studies

2 other study(ies) available for taurolidine and Liver Dysfunction

Article	Year
Pediatric Intestinal Failure: The Key Outcomes for the First 100 Patients Treated in a National Tertiary Referral Center During 1984-2017. JPEN. Journal of parenteral and enteral nutrition, 2018, Volume: 42, Issue:8 Topics: Catheter-Related Infections; Child; Child, Preschool; Digestive System Surgical Procedures; Female; Humans; Infant; Infant, Newborn; Intestinal Diseases; Intestine, Small; Intestines; Liver Diseases; Male; Parenteral Nutrition; Patient Care Team; Pediatrics; Retrospective Studies; Short Bowel Syndrome; Taurine; Tertiary Care Centers; Thiadiazines; Treatment Outcome	2018
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats. The Journal of surgical research, 2005, Volume: 129, Issue:1 Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Neoplasm Transplantation; Peritoneal Neoplasms; Rats; Taurine; Thiadiazines	2005

Article

Year

Pediatric Intestinal Failure: The Key Outcomes for the First 100 Patients Treated in a National Tertiary Referral Center During 1984-2017.

JPEN. Journal of parenteral and enteral nutrition, 2018, Volume: 42, Issue:8

Topics: Catheter-Related Infections; Child; Child, Preschool; Digestive System Surgical Procedures; Female; Humans; Infant; Infant, Newborn; Intestinal Diseases; Intestine, Small; Intestines; Liver Diseases; Male; Parenteral Nutrition; Patient Care Team; Pediatrics; Retrospective Studies; Short Bowel Syndrome; Taurine; Tertiary Care Centers; Thiadiazines; Treatment Outcome

2018

High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.

The Journal of surgical research, 2005, Volume: 129, Issue:1

Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical and Drug Induced Liver Injury; Colonic Neoplasms; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Kidney Diseases; Liver; Liver Diseases; Male; Neoplasm Transplantation; Peritoneal Neoplasms; Rats; Taurine; Thiadiazines

2005